ERBB2 and breast carcinoma: For SK-BR-3 cells, actein also inhibited about 53 and 77% migrated cells compared to the control wells, at 20 and 40 μM, respectively (Figure 2D), thereby suggesting the inhibitory effect of actein on the migration of HER2-positive human breast cancer cells.